Last reviewed · How we verify

NCT07206173

Londrina Activities of Daily Living Protocol in Pulmonary Hypertension

Recruiting now Last updated 25 November 2025
What this trial tests

trial testing The Londrina Activites of Daily Living Protocol in Pulmonary Hypertension in 32 participants. Currently enrolling.

Timeline
15 September 2025
Primary endpoint
15 December 2025
26 December 2025

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment32
Start date15 September 2025
Primary completion15 December 2025
Estimated completion26 December 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

18 and older, any sex, with Pulmonary Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational study is to evaluate the validity and reliability of the Londrina Daily Living Activities Protocol in patients diagnosed with pulmonary hypertension (PH).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pulmonary Hypertension

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07206173.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing